Cargando…

Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

BACKGROUND: Anakinra might improve the prognosis of patients with moderate to severe COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). We aimed to assess the effect of anakinra treatment on mortality in patients admitted to hospital with COVID-19. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kyriazopoulou, Evdoxia, Huet, Thomas, Cavalli, Giulio, Gori, Andrea, Kyprianou, Miltiades, Pickkers, Peter, Eugen-Olsen, Jesper, Clerici, Mario, Veas, Francisco, Chatellier, Gilles, Kaplanski, Gilles, Netea, Mihai G, Pontali, Emanuele, Gattorno, Marco, Cauchois, Raphael, Kooistra, Emma, Kox, Matthijs, Bandera, Alessandra, Beaussier, Hélène, Mangioni, Davide, Dagna, Lorenzo, van der Meer, Jos W M, Giamarellos-Bourboulis, Evangelos J, Hayem, Gilles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352496/ https://www.ncbi.nlm.nih.gov/pubmed/34396156 http://dx.doi.org/10.1016/S2665-9913(21)00216-2

Ejemplares similares

Anakinra for severe forms of COVID-19 – Authors' reply
por: Hayem, Gilles, et al.
Publicado: (2020)

Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis*
por: Karakike, Eleni, et al.
Publicado: (2021)

Anakinra for severe forms of COVID-19: a cohort study
por: Huet, Thomas, et al.
Publicado: (2020)

Effect of anakinra in COVID-19
por: Kooistra, Emma J, et al.
Publicado: (2020)

Antimicrobial Stewardship Using Biomarkers: Accumulating Evidence for the Critically Ill
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2022)

Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study.
por: Kaplanski, Gilles, et al.
Publicado: (2021)

An open label trial of anakinra to prevent respiratory failure in COVID-19
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Use of anakinra in severe COVID-19: A case report
por: Filocamo, Giovanni, et al.
Publicado: (2020)

Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
por: Kooistra, Emma J., et al.
Publicado: (2020)

Tocilizumab versus anakinra in COVID-19: results from propensity score matching
por: Arcani, Robin, et al.
Publicado: (2023)

The early change of SOFA score as a prognostic marker of 28-day sepsis mortality: analysis through a derivation and a validation cohort
por: Karakike, Eleni, et al.
Publicado: (2019)

Soluble fms-like tyrosine kinase 1, placental growth factor and procalcitonin as biomarkers of gram-negative sepsis: Analysis through a derivation and a validation cohort
por: Vittoros, Vasileios, et al.
Publicado: (2021)

Is Endothelial Activation a Critical Event in Thrombotic Thrombocytopenic Purpura?
por: Cauchois, Raphael, et al.
Publicado: (2023)

THE ROLE OF OBESITY AND PLASMA ADIPOCYTOKINES IN IMMUNE DYSREGULATION IN SEPSIS PATIENTS
por: de Nooijer, Aline H., et al.
Publicado: (2023)

Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
por: Dimopoulos, George, et al.
Publicado: (2020)

Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity
por: de Nooijer, Aline H., et al.
Publicado: (2023)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Proposal for a New Score: Hemorrhoidal Bleeding Score
por: Fathallah, Nadia, et al.
Publicado: (2021)

Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial
por: Leventogiannis, Konstantinos, et al.
Publicado: (2022)

Anakinra for patients with COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Past history of stage I/II solid tumor malignancy impacts considerably on sepsis mortality: a propensity score matching analysis from the hellenic sepsis study group
por: Dimοpoulos, George, et al.
Publicado: (2019)

Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
por: Pontali, Emanuele, et al.
Publicado: (2020)

BioFire(®) FilmArray(®) Pneumonia Panel for Severe Lower Respiratory Tract Infections: Subgroup Analysis of a Randomized Clinical Trial
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Presepsin as a diagnostic and prognostic biomarker of severe bacterial infections and COVID-19
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2023)

Efficacy of anakinra on rebound of multisystem inflammatory syndrome
por: Brisca, Giacomo, et al.
Publicado: (2022)

Anti-TNF-Alpha Therapy and Systemic Vasculitis
por: Jarrot, Pierre-André, et al.
Publicado: (2014)

Excess body weight is an independent risk factor for severe forms of COVID-19
por: Pietri, Léa, et al.
Publicado: (2021)

Anakinra in hospitalized COVID-19 patients guided by baseline soluble urokinase plasminogen receptor plasma levels: A real world, retrospective cohort study
por: Segala, Francesco Vladimiro, et al.
Publicado: (2023)

Association of Electrochemical Skin Conductance by Sudoscan and Cardiovascular Outcomes in Hemodialysis Patients
por: Touzot, Maxime, et al.
Publicado: (2022)

Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

PW02-011 - Favorable response to anakinra in aisle patients
por: Ozdogan, H, et al.
Publicado: (2013)

PW03-018 – Efficacy of Anakinra in recurrent pericarditis
por: Finetti, M, et al.
Publicado: (2013)

Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2013)

Electrochemical skin conductance by Sudoscan(®): a new tool to predict intradialytic hypotension
por: Reach, Pauline, et al.
Publicado: (2021)

A novel optical biosensor for the early diagnosis of sepsis and severe Covid-19: the PROUD study
por: Doulou, Sarantia, et al.
Publicado: (2020)

Age-related issues of instruments screening for autism in young children
por: Thomaidis, Loretta, et al.
Publicado: (2016)

The Place of Immunotherapy in the Management of HCV-Induced Vasculitis: An Update
por: Chiche, Laurent, et al.
Publicado: (2012)

Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study
por: Bozzi, Giorgio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f7sjp3hfruenpqjnbvqjumr5d2